Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Sramek

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
The New England Journal of Medicine|January 5, 1995
The use of placebo controlsJ J Sramek, N R Cutler
Journal of Clinical Pharmacology|November 15, 2000
Investigator perspective on MTD: practical application of an MTD definition--has it accelerated development?N R Cutler, J J Sramek
Alzheimer Disease and Associated Disorders|July 3, 1998
Guidelines for conducting bridging studies in Alzheimer diseaseN R Cutler, J J Sramek
European Journal of Clinical Pharmacology|January 1, 1995
Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging studyN R Cutler, J J Sramek
Drug Intelligence & Clinical Pharmacy|March 1, 1981
Psychotic exacerbation with haloperidolF L Tornatore, D Lee, J J Sramek
Drug Intelligence & Clinical Pharmacy|May 1, 1988
Neuroleptic plasma concentrations and clinical response: in search of a therapeutic windowJ J Sramek, S G Potkin, R Hahn
Drug Intelligence & Clinical Pharmacy|April 1, 1987
Efficacy of adjunctive carbamazepine in the treatment of chronic schizophreniaJ M Herrera, J J Sramek, J F Costa
The American Journal of Psychiatry|April 1, 1986
Neuroleptic dosage for Asians: a failure to replicateJ J Sramek, M A Sayles, G M Simpson
Expert Opinion on Investigational Drugs|April 3, 2001
The status of ongoing trials for mild cognitive impairmentJ J Sramek, A E Veroff, N R Cutler
Archives of Neurology|September 1, 1993
Poor tolerability of MK-458N R Cutler, J J Sramek, G A Block
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
The New England Journal of Medicine|January 5, 1995
The use of placebo controlsJ J Sramek, N R Cutler
Journal of Clinical Pharmacology|November 15, 2000
Investigator perspective on MTD: practical application of an MTD definition--has it accelerated development?N R Cutler, J J Sramek
Alzheimer Disease and Associated Disorders|July 3, 1998
Guidelines for conducting bridging studies in Alzheimer diseaseN R Cutler, J J Sramek
European Journal of Clinical Pharmacology|January 1, 1995
Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging studyN R Cutler, J J Sramek
Drug Intelligence & Clinical Pharmacy|March 1, 1981
Psychotic exacerbation with haloperidolF L Tornatore, D Lee, J J Sramek
Drug Intelligence & Clinical Pharmacy|May 1, 1988
Neuroleptic plasma concentrations and clinical response: in search of a therapeutic windowJ J Sramek, S G Potkin, R Hahn
Drug Intelligence & Clinical Pharmacy|April 1, 1987
Efficacy of adjunctive carbamazepine in the treatment of chronic schizophreniaJ M Herrera, J J Sramek, J F Costa
The American Journal of Psychiatry|April 1, 1986
Neuroleptic dosage for Asians: a failure to replicateJ J Sramek, M A Sayles, G M Simpson
Expert Opinion on Investigational Drugs|April 3, 2001
The status of ongoing trials for mild cognitive impairmentJ J Sramek, A E Veroff, N R Cutler
Archives of Neurology|September 1, 1993
Poor tolerability of MK-458N R Cutler, J J Sramek, G A Block
Pageof 11